APM
Avidity Partners Management Portfolio holdings
AUM
$499M
This Quarter Return
+6.37%
1 Year Return
+3.47%
3 Year Return
+181.12%
5 Year Return
+409%
10 Year Return
–
AUM
$3.92B
AUM Growth
+$3.92B
(+6%)
Cap. Flow
+$265M
Cap. Flow
% of AUM
6.75%
Top 10 Holdings %
Top 10 Hldgs %
36.15%
Holding
133
New
20
Increased
42
Reduced
20
Closed
29
Top Buys
| 1 |
Regeneron Pharmaceuticals
REGN
|
$92.2M |
| 2 |
AstraZeneca
AZN
|
$84.8M |
| 3 |
Baxter International
BAX
|
$69.3M |
| 4 |
Stevanato
STVN
|
$64.3M |
| 5 |
Caribou Biosciences
CRBU
|
$59.1M |
Top Sells
| 1 |
Maravai LifeSciences
MRVI
|
$124M |
| 2 |
Medtronic
MDT
|
$66.4M |
| 3 |
Biogen
BIIB
|
$63.7M |
| 4 |
NeoGenomics
NEO
|
$61.7M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$55.7M |
Sector Composition
| 1 | Healthcare | 97.34% |
| 2 | Technology | 1.13% |
| 3 | Financials | 0.61% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALPN
51
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $20.6M | 0.46% |
1,932,000
+437,000
| +29% | +$4.66M |
|
52
ESSA Pharma
EPIX
$11.3M
| $19.6M | 0.43% |
2,450,000
-300,000
| -11% | -$2.4M |
|
53
Adicet Bio
ACET
$61.8M
| $19M | 0.42% |
2,419,600
+169,100
| +8% | +$1.33M |
|
54
Century Therapeutics
IPSC
$42.4M
| $18.6M | 0.41% |
739,269
-264,253
| -26% | -$6.65M |
|
55
SI-BONE Inc
SIBN
$701M
| $17.8M | 0.39% |
831,200
+256,200
| +45% | +$5.49M |
|
56
Sana Biotechnology
SANA
$736M
| $17.4M | 0.39% |
774,644
-3,953
| -0.5% | -$89K |
|
57
UiPath
PATH
$5.82B
| $16.8M | 0.37% |
319,000
+19,000
| +6% | +$1,000K |
|
|
REUN
58
DELISTED
Reunion Neuroscience Inc. Common Shares
REUN
| $16.4M | 0.36% |
+3,581,000
| New | +$16.4M |
|
59
Lifestance Health
LFST
$2.15B
| $14.5M | 0.32% |
1,000,000
-100,000
| -9% | -$1.45M |
|
|
PHAS
60
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $13.7M | 0.3% |
4,405,000
+90,000
| +2% | +$280K |
|
61
GeneDx Holdings
WGS
$3.74B
| $12.6M | 0.28% |
1,660,000
+1,135,000
| +216% | +$8.61M |
|
62
GH Research
GHRS
$857M
| $12.4M | 0.27% |
560,000
| – | – |
|
|
LENZ
63
LENZ Therapeutics
LENZ
$1.1B
| $12.3M | 0.27% |
748,995
+13,495
| +2% | +$221K |
|
64
AC Immune
ACIU
$224M
| $11.7M | 0.26% |
1,739,600
+155,600
| +10% | +$1.04M |
|
65
SCYNEXIS
SCYX
$34.8M
| $10.9M | 0.24% |
2,060,000
| – | – |
|
66
Werewolf Therapeutics
HOWL
$60.4M
| $10.7M | 0.24% |
625,120
-25,145
| -4% | -$431K |
|
67
SentinelOne
S
$5.99B
| $10.7M | 0.24% |
200,000
| – | – |
|
|
HARP
68
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $9.41M | 0.21% |
1,190,600
-309,400
| -21% | -$2.44M |
|
|
ESMT
69
DELISTED
EngageSmart, Inc.
ESMT
| $9.37M | 0.21% |
+275,000
| New | +$9.37M |
|
70
Acadia Pharmaceuticals
ACAD
$4.31B
| $9.14M | 0.2% |
550,000
-390,000
| -41% | -$6.48M |
|
|
ORTX
71
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $8.83M | 0.2% |
3,836,798
+55,000
| +1% | +$127K |
|
|
CMAX
72
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $7.99M | 0.18% |
827,402
+10,000
| +1% | +$96.6K |
|
73
Zeta Global
ZETA
$4.53B
| $7.62M | 0.17% |
1,300,000
| – | – |
|
74
Instil Bio
TIL
$202M
| $7.3M | 0.16% |
408,140
+8,140
| +2% | +$146K |
|
75
Monte Rosa Therapeutics
GLUE
$312M
| $6.68M | 0.15% |
300,000
| – | – |
|